Schumer moves forward on Medicare drug price negotiations with Manchin's support — reports

Paul Schloesser

Associate Editor

Nicole DeFeudis

Editor

Months after Sen. Joe Manchin (D-WV) essentially squashed Democrats’ hopes of passing the Build Back Better Act, which included proposals to lower drug prices, a …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Schumer moves forward on Medicare drug price negotiations with Manchin's support — reports

Paul Schloesser

Associate Editor

Nicole DeFeudis

Editor

Sign up to read this article for free.

Among pharma CEOs, the IRA now and the IRA later get very different reactions

Bristol Myers restarts radiopharmaceutical Phase 3 trial, but delays readout by one year

Updated: With cost-cutting underway, Bristol Myers raises guidance, touts Phase 3 win and scraps another

Andrew Left, short seller who campaigned against Valeant, is accused of fraud by SEC

European drug regulator rejects Alzheimer's drug Leqembi, citing safety concerns

Critical Junctures in Gene Therapy Clinical Material Manufacturing: Where Do I Start? And Will It Work?

Schumer moves for­ward on Medicare drug price ne­go­ti­a­tions with Manch­in's sup­port — re­ports

Associate Editor

Editor

Sign up to read this article for free.

Schumer moves forward on Medicare drug price negotiations with Manchin's support — reports